AHA Archives

Development and disease in the aorta

Apr. 2, 2014—Smooth muscle cells that line the aorta differ in development but not in the adult, a finding that has implications for understanding aortic development and disease.

E-records shed light on drug response

Mar. 31, 2014—Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response.

Shining a light on night blindness

Oct. 24, 2013—Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.

Motor protein revs up cell division

Jul. 29, 2013—A motor protein that helps drive cell division may be a promising new target for cancer therapeutics.

Reducing fatal rhythms after heart attack

Jul. 26, 2013—Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.

Acetaminophen: protective in sepsis?

Mar. 28, 2013—In critically ill patients with sepsis, plasma hemoglobin may be a new indicator of disease severity – and a potential target for treatment with acetaminophen.

Cell connections key in valve disease

Feb. 14, 2013—A protein that connects cells together participates in the calcification that occurs in heart valve disease.

Cell source of heart’s blood vessels

Feb. 1, 2013—An unexpected group of cells generates the coronary arteries and may be useful for regeneration therapies following injury to the heart.

Preventing hardened heart valves

Dec. 26, 2012—Blocking a serotonin receptor may provide a novel therapy for heart valve disease.

Heart Association honors Roden’s research efforts

Nov. 15, 2012—Dan Roden, M.D., assistant vice chancellor for Personalized Medicine and William Stokes Professor of Experimental Therapeutics, received a 2012 Distinguished Scientist Award at the annual Scientific Sessions of the American Heart Association (AHA) last week in Los Angeles.